William Frels - Mairs & Power
Holding/activity history for Edwards Lifesciences Corp. (EW)
← All EW superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $68.95–94.34 · VW $78.35i | SEC | |
| 2023 Q2 | 2,938 | <0.01 | Reduce 16.01% | <0.01 | $80.94–94.87 · VW $87.32i | $277,142 | SEC |
| 2023 Q1 | 3,498 | <0.01 | Buy | <0.01 | $73.54–84.85 · VW $79.14i | $289,390 | SEC |
| 2022 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $96.39–129.53 · VW $111.53i | SEC | |
| 2021 Q4 | 1,593 | <0.01 | Buy | <0.01 | $105.66–131.73 · VW $116.75i | $206,000 | SEC |
| 2020 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $56.44–78.43 · VW $70.72i | SEC | |
| 2020 Q1 | 4,443 | <0.01 | $62.80 | $279,000 | SEC | ||
| 2019 Q4 | 4,443 | <0.01 | Add 12.20% | <0.01 | $71.08–82.55 · VW $78.43i | $346,000 | SEC |
| 2019 Q3 | 3,960 | <0.01 | $73.23 | $290,000 | SEC | ||
| 2019 Q2 | 3,960 | <0.01 | $61.62 | $244,000 | SEC | ||
| 2019 Q1 | 3,960 | <0.01 | $63.89 | $253,000 | SEC | ||
| 2018 Q4 | 3,960 | <0.01 | $51.01 | $202,000 | SEC | ||
| 2018 Q3 | 3,960 | <0.01 | Buy | <0.01 | $44.84–58.33 · VW $50.31i | $230,000 | SEC |
| 2001 Q4 | 0 | 0.00 | Sell 100.00% | 0.07 | $1.88–2.43 · VW $2.14i | SEC | |
| 2001 Q3 | 691,908 | 0.07 | Reduce 0.31% | <0.01 | $1.70–2.33 · VW $2.04i | $1,291,562 | SEC |
| 2001 Q2 | 694,092 | 0.17 | Reduce 1.21% | <0.01 | $1.48–2.20 · VW $1.93i | $1,524,689 | SEC |
| 2001 Q1 | 702,588 | 0.07 | Reduce 0.27% | <0.01 | $1.40–1.90 · VW $1.59i | $1,147,560 | SEC |
| 2000 Q4 | 704,508 | 0.06 | Reduce 1.71% | <0.01 | $1.00–2.04 · VW $1.34i | $1,042,085 | SEC |
| 2000 Q3 | 716,748 | 0.08 | Reduce 11.25% | <0.01 | $1.57–2.20 · VW $1.90i | $1,302,839 | SEC |
| 2000 Q2 | 807,636 | 0.08 | Buy | 0.08 | $1.03–1.75 · VW $1.36i IPO/listing quarter |
$1,245,105 | SEC |
Price snapshot:
Current price$91.79
52-week low$72.30
52-week high$96.29